|
|
Volumn 120, Issue 19, 2014, Pages 2986-2995
|
|
Effects of metformin on endometrial cancer cell growth in vivo: a preoperative prospective trial.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDIABETIC AGENT;
ANTINEOPLASTIC AGENT;
CYCLINE;
DNA BINDING PROTEIN;
DNA TOPOISOMERASE (ATP HYDROLYSING);
DNA TOPOISOMERASE II ALPHA;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE;
KI 67 ANTIGEN;
MAPK1 PROTEIN, HUMAN;
METFORMIN;
MITOGEN ACTIVATED PROTEIN KINASE 1;
MITOGEN ACTIVATED PROTEIN KINASE KINASE;
MTOR PROTEIN, HUMAN;
P27 ANTIGEN;
PROTEIN S6;
TARGET OF RAPAMYCIN KINASE;
TUMOR ANTIGEN;
ADJUVANT CHEMOTHERAPY;
ADJUVANT THERAPY;
ADULT;
AGED;
ARTICLE;
CANCER GRADING;
CANCER STAGING;
CELL PROLIFERATION;
CLINICAL TRIAL;
DRUG EFFECT;
ENDOMETRIOID CARCINOMA;
ENDOMETRIUM CANCER;
ENDOMETRIUM TUMOR;
FEMALE;
GROWTH INHIBITION;
HUMAN;
IMMUNOHISTOCHEMISTRY;
IN VIVO;
INSULIN RESISTANCE;
METABOLISM;
METHODOLOGY;
MIDDLE AGED;
PATHOLOGY;
PROSPECTIVE STUDY;
SIGNAL TRANSDUCTION;
TUMOR CELL LINE;
WESTERN BLOTTING;
ENDOMETRIAL CANCER;
GROWTH INHIBITION;
IN VIVO;
INSULIN RESISTANCE;
METFORMIN;
ADULT;
AGED;
AMP-ACTIVATED PROTEIN KINASES;
ANTIGENS, NEOPLASM;
ANTINEOPLASTIC AGENTS;
BLOTTING, WESTERN;
CARCINOMA, ENDOMETRIOID;
CELL LINE, TUMOR;
CELL PROLIFERATION;
CHEMOTHERAPY, ADJUVANT;
DNA TOPOISOMERASES, TYPE II;
DNA-BINDING PROTEINS;
ENDOMETRIAL NEOPLASMS;
FEMALE;
HUMANS;
HYPOGLYCEMIC AGENTS;
IMMUNOHISTOCHEMISTRY;
KI-67 ANTIGEN;
MAP KINASE SIGNALING SYSTEM;
METFORMIN;
MIDDLE AGED;
MITOGEN-ACTIVATED PROTEIN KINASE 1;
MITOGEN-ACTIVATED PROTEIN KINASE KINASES;
NEOADJUVANT THERAPY;
NEOPLASM GRADING;
NEOPLASM STAGING;
PROLIFERATING CELL NUCLEAR ANTIGEN;
PROSPECTIVE STUDIES;
RIBOSOMAL PROTEIN S6;
TOR SERINE-THREONINE KINASES;
|
|
EID: 84908498848
PISSN: None
EISSN: 10970142
Source Type: Journal
DOI: 10.1002/cncr.28853 Document Type: Article |
|
Times cited : (112)
|
|
References (0)
|
